Debut Plus

₹1,468.4

▼ -30.43 -2.03%

As of 23 Oct 2026 · delayed

NSE Listed

Entero Healthcare Solutions Ltd. (ENTERO)

Volume: 2,15,286Avg Vol 1W: 1,28,629.8Avg Vol 1M: 1,15,763.452W Range:₹944₹1,920
NSE BSE www.enterohealthcare.com AI Report
Key Ratios
Checked 15h ago
Market Cap₹6,391 Cr
Current Price₹1,468.4
Previous Close₹1,498.83
High / Low (52w)₹1,920 / ₹944
Volume2,15,286
Avg Vol (1W)1,28,629.8
Avg Vol (1M)1,15,763.4
Stock P/E52.16
Book Value₹395.31
Dividend Yield—
ROE6.3%
ROA—
Revenue (TTM)₹5,135 Cr
Revenue Growth—
Profit Margin—
Total Debt₹0 Cr
Shares Outstanding—
Face Value₹10
EPS (TTM)₹24.69
P/B2.88
Debt / Equity0.22
50 DMA₹1,669.24
200 DMA₹1,298.87
Day change-2.03%
Price Chart
₹1,468.4▲ 32.53% · 1Y
₹1898₹94922.3L
2025-10-27
2026-10-23

20-day avg volume: 1.2L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 24% YoY.
  • Stock trades at a high P/E of 52.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹1,301 Cr₹1,359 Cr₹1,339 Cr₹1,404 Cr₹1,571 Cr₹1,707 Cr₹1,910 Cr₹1,941 Cr
EBITDA₹46 Cr₹49 Cr₹48 Cr₹47 Cr₹57 Cr₹63 Cr₹75 Cr₹88 Cr
Net Profit₹24 Cr₹25 Cr₹26 Cr₹28 Cr₹32 Cr₹28 Cr₹28 Cr₹38 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹5,135 Cr₹72 Cr₹79 Cr₹83 Cr₹107 Cr₹79 Cr₹6,610 Cr₹83 Cr
EBITDA₹180 Cr₹12 Cr₹10 Cr₹8 Cr₹7 Cr₹15 Cr₹242 Cr₹10 Cr
Net Profit₹95 Cr₹-28 Cr₹7 Cr₹6 Cr₹1 Cr₹13 Cr₹115 Cr₹3 Cr
EPS21.76—————26.4—
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹749 Cr₹836 Cr₹1,126 Cr₹1,309 Cr₹2,345 Cr₹2,703 Cr₹3,600 Cr
Total Liabilities₹325 Cr₹349 Cr₹563 Cr₹711 Cr₹704 Cr₹932 Cr₹1,848 Cr
Equity₹424 Cr₹487 Cr₹563 Cr₹598 Cr₹1,641 Cr₹1,770 Cr₹1,753 Cr
Total Debt———————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹-32 Cr₹-64 Cr₹-24 Cr₹-33 Cr₹-24 Cr₹-39 Cr₹150 Cr
Investing₹-203 Cr₹-31 Cr₹-162 Cr₹-49 Cr₹-705 Cr₹220 Cr₹-303 Cr
Financing₹217 Cr₹89 Cr₹211 Cr₹73 Cr₹863 Cr₹-74 Cr₹124 Cr
Free Cash Flow₹-32 Cr₹-64 Cr₹-24 Cr₹-33 Cr₹-24 Cr₹-39 Cr₹150 Cr
Shareholding
Promoter 52.4% Institutions 26.93% Public 20.67%
Efficiency & Working Capital
ROCE9.7%
Interest Coverage4.3
Dividend Payout—
Debtor Days67 d
Inventory Days47 d
Payable Days40 d
Cash Conversion Cycle74 d
Working Capital Days114 d
Shareholding Details

As of 2026-09-30

Promoter52.4%
FII5.8%
DII21.2%
Institutions26.9%
Public20.7%
Promoter Pledge0%
No. of Shareholders40,919
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodFeb 2024Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters52.4%52.4%52.4%52.4%52.4%52.4%52.4%52.4%52.4%52.4%52.4%52.4%
FIIs22.8%23.3%23.3%23.8%22.2%19.9%17.2%14.7%5.1%4%4.4%5.8%
DIIs1.4%2.3%2.1%7.7%8.8%9.6%10.2%9.6%16.4%16.6%15.5%21.2%
Public23.4%22%22.2%16%16.6%18%20.2%23.3%26%26.9%27.8%20.7%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,14,26080,86466,40036,76733,17233,15933,33836,33440,33339,08439,71040,919
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Orbimed Asia Iii Mauritius LimitedShareholding of Promoter and Promoter Group38%1.65 Cr
Prabhat AgrawalShareholding of Promoter and Promoter Group9.3%40,28,395
Prem SethiShareholding of Promoter and Promoter Group5.2%22,39,842
Hdfc Mutual Fund - Hdfc Pharma And Healthcare FundPublic Shareholding3.2%13,90,000
Invesco India Contra FundPublic Shareholding3.2%13,88,340
Surbhi Singh(prasid Uno Family Trust)Public Shareholding3.1%13,25,420
3p India Equity Fund 1Public Shareholding3%13,17,934
Bank Of India Flexi Cap FundPublic Shareholding2.4%10,46,507
Cif Iii Scheme IPublic Shareholding1.5%6,68,060
3p India Equity Fund 1mPublic Shareholding1.2%5,11,500
Ajay Kumar AggarwalPublic Shareholding1%4,37,715
Technomax InfosolutionsShareholding of Promoter and Promoter Group0%0
Union Quimico Farmaceutica Sau SpainShareholding of Promoter and Promoter Group0%0
Holliday International LtdShareholding of Promoter and Promoter Group0%0
Soneas Chemicals HungaryShareholding of Promoter and Promoter Group0%0
Orbimed Asia Partners Iii, L.p.Shareholding of Promoter and Promoter Group0%0
Uquifa Sciences Mascarene Ltd MauritiusShareholding of Promoter and Promoter Group0%0
Uquifa Sciences Uk LtdShareholding of Promoter and Promoter Group0%0
Uquifa Sciences Slu SpainShareholding of Promoter and Promoter Group0%0
Uquifa Mexico Sa MexicoShareholding of Promoter and Promoter Group0%0
Uquifa India LimitedShareholding of Promoter and Promoter Group0%0
Richa AgarwalShareholding of Promoter and Promoter Group0%300
Arti MittalShareholding of Promoter and Promoter Group0%143
Payal AgrawalShareholding of Promoter and Promoter Group0%0
Kunjbehari Lal AgrawalShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Sujesh VasudevanChairman & Independent Directo2026
Prabhat AgrawalManaging Director & CEO2026
Prem SethiExecutive Director / WTD / Chief Operating Officer2026
SANDHYA SHARMAIndependent Non Exe. Director2026
Sumona ChakrabortyNon Independent Non Executive Director / Nominee2026
Arun SadhanandhamNon Independent Non Executive Director / Nominee2026
Kevin Rohitbhai DaftaryNon Independent Non Executive Director / Nominee2026
SANU VISHAL KAPOORVP / Company Secretary / Compliance Officer2026
Segments — Product
SegmentRevenueShare
Trading of Pharmaceutical and Surgi₹0 Cr—
Segments — Geography
RegionRevenueShare
Domestic₹348 Cr100%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10754444
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-07Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20263,685001003,695
20263,27800003,278
20261490090159
Insider / Designated-Person Trades

3 recent disclosure(s)

Jayant PrakashDisposal · 2,179
Jayant PrakashDisposal · 1,350
Abhitsh KumarDisposal · 1,200
Substantial Acquisitions (SAST)

3 disclosure(s)

Bulk Deal17/09/2026 · 21,30,000
Market29/12/2025 · 22,77,083
Market29/12/2025 · 21,82,039
Company Information
Incorporated2018
ChairmanSujesh Vasudevan
AuditorMSKA & Associates LLP
Investor Email[email protected]
🌐 www.enterohealthcare.com ↗

📍 Plot # I-35 Bldg-B Ind. Area, Phase-I 13/7 Mathura Road, Faridabad, Haryana, 121003

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Enfuse Solutions LimitedEngineers India Ltd.Entertainment Network (India) Ltd.Enkei Wheels (India) Ltd.Siemens Energy India Ltd.Enser Communications Ltd.Envirotech Systems Ltd.Epack Durable LimitedEPack Prefab Technologies Ltd.Epigral LimitedEPL LimitedEPW India LimitedAll “E” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search